Table 26: Adjusted Target Vessel Revascularization Rates of Drug-Eluting Stent Versus Bare Metal Stents in Ontario Field Evaluation of Drug-Eluting Stents.
| Drug-eluting stents (%) | Bare metal stents (%) | P value | |||
|---|---|---|---|---|---|
| Non-post MI, non- diabetic | |||||
| All lesions | 5.4 | 7.2 | NS | ||
| Long lesions | 4.7 | 9.0 | < .05 | ||
| Narrow lesions | 6.4 | 10.7 | < .05 | ||
| Long or narrow lesions | 5.4 | 9.5 | < .05 | ||
| Non-post MI, diabetic | |||||
| Long lesions | 7.9 | 18.6 | < .05 | ||
| Narrow lesions | 5.7 | 11.9 | < .05 | ||
| Long & narrow lesions | 6.0 | 20.6 | < .05 | ||
| Long or narrow lesions | 6.9 | 14.3 | < .05 | ||
Bowen et al., 2005 (5)
MI myocardial infarction